Analystreport

Sutro Biopharma (NASDAQ:STRO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

Sutro Biopharma, Inc.  (STRO) 
Last sutro biopharma, inc. earnings: 11/8 07:00 am Check Earnings Report